David Evans

BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Immunodiagnostic Systems Holdings Plc engages in the development, manufacture, and marketing of in-vitro diagnostic tests (IVD) to the clinical laboratory market. The company was founded in 1977 and is headquartered in Boldon, the United Kingdom.

Source Bioscience (Healthcare) Ltd. manufactures environmental control products for the pharmaceutical industry, life sciences and food sectors. It provides products and services for the management of temperature, humidity and light, where controlled storage is required. Its product range includes controlled environment rooms and storage chambers, blood bank storage units and plant growth chambers. The company was founded in 2003 and is headquartered in Nottingham, the United Kingdom.

Chromogenex Plc designs, manufactures, and distributes laser and intense pulsed light systems. The company offers laser and light technology for aesthetic applications such as laser hair removal, skin rejuvenation, acne treatment, IPL Laser, and vascular lesions. Its products include Chromolite and Nlite-V. The company was founded in 1985 and is headquartered in Llanelli, UK.

BgenuineTec Inc. engages in the development and sale of biometric technology products. The company provides biometric certification and authentication services, physical access systems, fingerprint image sensors, and related software. The company was founded in November 2005 and is headquartered in Tokyo, Japan.

Epistem Ltd. engages in the provision of research solutions. It offers laser capture microdissection, imaging; microbiome, gene expression, NGS, DNA genotyping, and plucked hair analysis; Histology and IHC, and analytical services. The company was founded by Christopher Stanislaus Potten, Catherine Booth and Julie Tudor in 2000 and is headquartered in Manchester, the United Kingdom.

Axis-Shield Ltd. operates as a biotechnology company. The company was founded 1993 and is headquartered in the United Kingdom.

International Brand Licensing Plc ownership of the Admiral and Muscle Athletic sports and fashion brands which it exploits through a licensing business model. The company through the licensing of its trademark registrations to licensees in various territories around the world, receives revenues through royalties and minimum guarantees. The company engages in the developing and exploiting portfolio of sports and lifestyle brands, trademarks, trade names and logos. It seeks to exploit the value of its brands by granting licenses to third parties authorising manufacture, marketing and sale of specified licensed products for a fixed term by reference to a particular territory. International Brand Licensing was founded in 2002 and is headquartered in London.

Part of BBI Diagnostics Group Ltd., British Biocell International Ltd. is a private group led by Julian Baines. The company is based in Cardiff, UK. British Biocell International was acquired by BBI Diagnostics Group Ltd. on January 31, 2001.

Part of Revvity, Inc., Immunodiagnostic Systems Ltd. is a British company that manufactures and markets manual immunoassays and automated immunoanalyser technologies to improve diagnostic outcomes for patients. The company is based in Boldon, UK. IDS also conducts research in other areas and offers hypertension immunoassays such as Renin assays and Aldosterone assays. The IDS about us section provides information on corporate history and strategic vision. The company was founded in 1995 by Robert William Cunningham.

Part of Cardinal Health, Inc., Electro Medical Equipment Ltd manufactures medical devices and disposables for the non-invasive treatment of newborns with respiratory problems. The company is based in Brighton, UK. Electro Medical Equipment was acquired by VIASYS Healthcare, Inc. on October 17, 2002 for $22.33 million.

Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

Storyland Ltd broadcasts children's television programs and publishes children's books.

Acolyte Biomedica Ltd. develops, manufactures, and markets microbiology and cell enumeration systems for clinical diagnostics and life sciences research. Its products include baclite rapid and rapitect. The company was founded in February 2000 and is headquartered in Salisbury, UK.

Quotient Diagnostics Ltd. develops diabetes testing technology. It offers pharmaceuticals, in vitro diagnostics and medical devices. The company was founded in December 2002 and is headquartered in Walton-on-Thames, the United Kingdom.

Harnessing the power of novel light-harvesting polymeric materials, Sirigen's amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces. The company's versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications. Its platform agnostic, enabling technology represents a quantum leap in detection capabilities, amplifying the sensitivity of a wide range of existing instrumentation and detection platforms by up to 100 fold. The company's technology is applicable to a diverse cross section of the biomedical industry including the $6billion drug discovery industry which can use it to test the efficacy of new drugs, the $12billion life sciences industry which can use Sirigen to develop new detection platforms, and the $35billion diagnostics industry, which can work with the company to optimise existing diagnostic techniques and to develop the next generation of diagnostic tools. Indeed the potential to deliver real time testing on miniaturised monitoring devices is close to reality.

The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright.

The UK Innovation & Science Seed Fund LP, an evergreen fund, invests in seed-stage companies located in the United Kingdom. It targets companies operating in biotechnology, synthetic biology, engineering, agriculture, computer science, and environmental technology sectors. It provides equity financing for seed to early-stage transactions.

Haptogen Ltd. manufactures biopharmaceuticals products. The company was founded by Jim Reid in 2002 and is headquartered in Aberdeen, UK.

Platform Diagnostics Ltd. develops vitro diagnostics products. It develops POC diagnostic devices based on capillary agglutination technology, a reagent that combines with an analyte in blood and urine samples, and forms an agglutinate of molecules. The company was founded by Damian Bond in 2002 and is headquartered in Ossett, the United Kingdom.

Part of Carclo Plc, Electromedical Ltd. operates as a British dormant company. The company is based in Ossett, UK.

Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom.

Microtest Matrices Ltd. provides automated multiplex in-vitro diagnostic tests. It offers services in the areas of Allergy, Autoimmune, Influenza and Infectious Disease. The company was founded by Tito Adolfo Bacarese-Hamilton, Henry Charles Hyde-Thomson, and Andrea Crisanti in 2000 and is headquartered in London, the United Kingdom.

DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom.

Onyx Scientific Ltd. provides pharmaceutical chemistry services. It offers lead optimization, chemical synthesis and process development, solid state chemistry, generic formulations, and pharmaceutical testing services. The company was founded by Denise Bowser and Anthony Flinn in 2000 and is headquartered in Sunderland, the United Kingdom.

Scottish Enterprise Tayside Ltd. is a national economic development agency founded in 1990. The British company operates to promote economic growth and development in Scotland.

Part of Ipca Laboratories Ltd., Onyx Research Chemicals Ltd. is a British company that operates as a parent company. The company is based in Sunderland, UK.

Momentum Bioscience Ltd. develops a technology for the detection of infection in blood and other normally sterile body fluids. Its solutions include EMA Sepsis, a detection method for organisms in blood; EMA Total, a detection method for organisms in NSF; EMA Bacteria for the detection of bacteria; and EMA Fungi for the detection of fungi. The company was founded by William Henry Mullen in 2008 and is headquartered in Cardiff, the United Kingdom.

Bamburgh Capital Ltd. provides financial management services. Its services include strategic advisory, Initial Public Offering advisory, Equity Capital Markets advisory, mergers and acquisitions and disposal. The firm operates through its offices located in Manchester, Newcastle and Edinburgh. The company is headquartered in Manchester, the United Kingdom.

Part of Optibiotix Health Plc, Optibiotix Ltd. is a British company that develops biological products for digestive health. The company is based in Heslington, UK. The company was founded in 2012 by Stephen Patrick O'Hara, who has been the CEO since 2012. Optibiotix was acquired by Optibiotix Health Plc on August 05, 2014 for $122.72 million.

Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland.

Source Bioscience Healthcare manufactures and supplies analytical testing laboratory products and provides laboratory services. The private company is based in Nottingham, UK.

Collagen Solutions (UK) Ltd. manufactures medical grade biomedical collagen components for use in regenerative medicines, medical devices, and in-vitro diagnostics. It offers reagents and protocols; and specific collagen formulations for applications, such as sponges, films, and powders. The company is headquartered in London, the United Kingdom.

Healthcare Investment Opportunities Plc operates as a development stage company and has not yet commenced principal operations. The company's principal business activities are that of an investing company focusing on opportunities in the healthcare sector. Healthcare Investment Opportunities was founded on March 15, 2013 and is headquartered in Manchester, the United Kingdom.

Collagen Solutions (US) LLC is a holding company, which engages in the supply, development, and manufacture of medical grade collagen components and biomaterials. The company offers products for the use in regenerative medicine, medical devices, and in-vitro diagnostics and research. It operates through the following geographical segments: Europe, Middle East, and Africa; North America; and Asia. The company was founded on March 15, 2013 and is headquartered in Glasgow, the United Kingdom.

Part of Novacyt SAS, Yourgene Health UK Ltd. is a company that engages in developing prenatal diagnostic products for molecular testing laboratories. Yourgene Health UK Ltd. is based in Manchester, UK. Yourgene Health was acquired by ViaLogy Plc on July 04, 2014 for $64.97 million. The British company was founded in 2013.

Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. It primarily manufactures molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. It operates through the Genomic Technologies and Genomic Services segments. The Genomic Technologies segment represents the in vitro diagnostic products, software and instrumentation manufactured by the group. The Genomic Services segment operates testing laboratories in Taiwan and the UK, and provides services to clinicians, third party clinical service providers and contract research organizations. The company was founded on April 13, 2000 and is headquartered in Manchester, the United Kingdom.

Diagnostic Capital provides investment advice.

Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom.

MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.

Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom.